A Global Perspective/Health Inequity in Heart Failure, An Issue of Heart Failure Clinics

Name: A Global Perspective/Health Inequity in Heart Failure, An Issue of Heart Failure Clinics | Global Perspective/Health Inequity in Heart Failure, An Issue of Heart Failure Clinics,
Brand: Elsevier
Price: 71.39 EUR
Availability: OnlineOnly

Global Perspective/Health Inequity in Heart Failure, An Issue of Heart Failure Clinics,

Pablo Castro(Autor*in)

Elsevier (Verlag)

1. Auflage

Erschienen am 7. Januar 2016

100 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

E-Book

PDF mit Adobe-DRM

Systemvoraussetzungen

978-0-323-40087-9 (ISBN)

71,39 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM und PDF mit Adobe-DRM

(Hinweis: Die Auswahl des von Ihnen gewünschten Dateiformats und des Kopierschutzes erfolgt erst im System des E-Book Anbieters)

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Front Cover
A Global Perspective/HealthInequity in Heart Failure
Copyright
Contributors
CONSULTING EDITORS
EDITORS
AUTHORS
Contents
Foreword: Heart Failure: A Global Pandemic and Not Just a Disease of the West
Socioeconomic Inequalities in Heart Failure
Heart Failure in Rural Communities
Inequalities in the Access to Advanced Therapy in Heart Failure
Gaps and Resemblances in Current Heart Failure Guidelines: A Clinical Perspective
Prognostic Factors in Hospitalization for Heart Failure in Asia
Biomarkers for Heart Failure in Asia
Heart Transplant in Asia
Epidemiology of Heart Failure in Asia
Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Fail .
Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations
The Impact of Worsening Heart Failure in the United States
End-of-life Heart Failure Care in the United States
Epidemiology of Heart Failure in Europe
Acute Heart Failure Syndromes in the Elderly: The European Perspective
Characteristics of Intensive Care in Patients Hospitalized for Heart Failure in Europe
HEART FAILURE CLINICS
FORTHCOMING ISSUES
January 2016
April 2016
RECENT ISSUES
July 2015
April 2015
Preface: Heart Failure: A Global Pandemic and Not Just a Disease of the West
Socioeconomic Inequalities in Heart Failure
Key points
BACKGROUND
SOCIOECONOMIC STATUS AND HEART FAILURE
EDUCATIONAL LEVEL AND OCCUPATION
HEALTH LITERACY AND HEART FAILURE
BRIDGING THE GAPS IN SOCIOECONOMIC INEQUALITY
FUTURE DIRECTIONS
SUMMARY
REFERENCES
Heart Failure in Rural Communities
Key points
BACKGROUND
EPIDEMIOLOGY
ORGANIZATIONAL FACTORS IN RURAL HEALTH SYSTEMS
Health System Policies
Health Care Providers' Adherence to Guidelines in the Rural Setting
PATIENT-RELATED FACTORS IN RURAL COMMUNITIES
ROLE OF INTERVENTIONS TO IMPROVE CHRONIC HEART FAILURE OUTCOMES IN RURAL COMMUNITIES
Simplified Diagnostic Approach
Telemedicine Support
Patient Education
Primary Health Care Provider Education and Training
SUMMARY
REFERENCES
Inequalities in the Access to Advanced Therapy in Heart Failure
Key points
INTRODUCTION
SOME DEFINITIONS
Developing Countries
The Chilean Health Care Model, as a Model of a Developing Country
Defining Advanced Heart Failure
GENERAL APPROACH TO ADVANCED THERAPIES AND INTRODUCTION TO THE PROBLEM OF INEQUALITIES
Cardiac Resynchronization Therapy and Implantable Cardioverter-Defibrillators
Mechanical Cardiac Support
Heart Transplant
OTHER FACTORS THAT MAKE DIFFICULT THE ACCESS TO ADVANCED THERAPIES
Economic Issues
Access to Health Care
Low Number of Heart Failure Specialists
SUMMARY
REFERENCES
Gaps and Resemblances in Current Heart Failure Guidelines
Key points
INTRODUCTION
GRADING THE EVIDENCE AND CLASSIFYING THE RECOMMENDATIONS
DEFINITIONS AND TYPES OF HEART FAILURE
PHARMACOLOGIC TREATMENT IN HEART FAILURE
Angiotensin I-Converting Enzyme Inhibitors
Angiotensin Receptor Blockers
Mineralocorticoid Receptor Antagonists
ß-Blockers
Digoxin
Hydralazine and Isosorbide
Oral Anticoagulants
NOVEL TREATMENTS
Ivabradine
Angiotensin Receptor-Neprilysin Inhibitors
DEVICE RECOMMENDATIONS IN HEART FAILURE
Cardiac Resynchronization Therapy
Implantable Cardioverter-Defibrillators for Primary Prevention
SUMMARY
REFERENCES
Prognostic Factors in Hospitalization for Heart Failure in Asia
Key points
INTRODUCTION
PROGNOSTIC FACTORS OF MORTALITY AND MORBIDITY
Age
Hyponatremia
Systolic Blood Pressure
Renal Dysfunction
Left Ventricular Function
Ventricular Conduction Disturbance
Anemia
Evidence-based Medication Adherence
Hospitalization
EMERGING PROGNOSTIC FACTORS
Hemoconcentration
OTHER PROGNOSTIC FACTORS
SUMMARY
REFERENCES
Biomarkers for Heart Failure in Asia
Key points
INTRODUCTION
KEY PLAYERS
JAPAN AND THE NATRIURETIC PEPTIDE STORY
THE HONG KONG HERITAGE IN BIOMARKERS FOR HEART FAILURE
NEW DEVELOPMENTS FROM ASIA IN BIOMARKERS FOR HEART FAILURE
Peptide Biomarkers for Heart Failure in Asia
News on Nonpeptide Markers from Asia
Nucleic Acids as Biomarkers in Heart Failure
Genotyping for Heart Failure in Asia
Asia Is Organizing
Markers When East Meets West
REFERENCES
Heart Transplant in Asia
Key points
INTRODUCTION
HEART FAILURE IN ASIA
Prevalence of Heart Failure
Patients' Characteristics of Heart Failure in Asia
Advanced Heart Failure in Asia
Heart Failure Management in Asia
Heart Failure Outcome in Asia
HEART TRANSPLANT IN ASIA
History
Incidence and Prevalence
Recipient and Cause of End-Stage Heart Disease
Screening for Donors
Survival
HEART TRANSPLANT IN SPECIAL SITUATIONS
Rheumatic Heart Disease
Elderly
Hepatitis B Virus Infection
POST-HEART TRANSPLANT CARE
Immunosuppression and Rejection
Endomyocardial Biopsy
HEART TRANSPLANT COMPLICATION
Primary Graft Failure
Cardiac Allograft Vasculopathy
Cardiac Arrhythmia
Malignancy
Infection
Mechanical Circulatory Support Devices in Asia
Barriers and Key to Success in Heart Transplant Program in Asia
Law
Ethical Issue
Infrastructure
Donor Shortage
Limitation of Data
Future
SUMMARY
REFERENCES
Epidemiology of Heart Failure in Asia
Key points
INTRODUCTION
IMPORTANT ISSUES FOR EPIDEMIOLOGIC COMPARISON
Definitions of Heart Failure in Registries of Patients Hospitalized for Heart Failure
Site Selection
The Time Frame
Ethnic Differences
EPIDEMIOLOGIC COMPARISON OF PATIENTS HOSPITALIZED FOR HEART FAILURE IN ASIA
Patient Characteristics
Management
Outcome
SUMMARY
REFERENCES
Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America
Key points
INTRODUCTION
BARRIER: POOR VISIBILITY OF CARDIOVASCULAR DISEASE AND CLINICAL TRIALS WITHIN THE INSTITUTION AND THE BROADER COMMUNITY
BARRIER: INABILITY OF STUDY SPONSORS TO IDENTIFY SITES CAPABLE OF ENROLLING HIGH VOLUME AND QUALITY PATIENTS
BARRIER: TIME-CONSUMING STUDY PROTOCOLS THAT DO NOT REFLECT THE DAY-TO-DAY REALITIES OF PATIENT CARE
BARRIER: INADEQUATE INFRASTRUCTURE FOR RECRUITMENT OF PARTICIPANTS AND STUDY CONDUCT
BARRIER: UNDERDEVELOPED RELATIONSHIPS BETWEEN CARDIOLOGISTS AND OTHER PHYSICIANS CARING FOR THE CARDIAC PATIENT
BARRIER: MISALIGNMENT OF INCENTIVES BETWEEN PRINCIPLE INVESTIGATORS AND PARENT CLINICAL FACILITY
BARRIER: LIMITED UPFRONT TRAINING AND ONGOING SUPPORT FOR STUDY COORDINATORS AND OTHER STAFF
SUMMARY
REFERENCES
Hospitalized Heart Failure in the United States
Key points
UNITED STATES STUDY ENROLLMENT
PATIENT CHARACTERISTICS
LENGTH OF STAY AND READMISSION RISK
THERAPY UTILIZATION
CLINICAL OUTCOMES
POTENTIAL FUTURE DIRECTIONS FOR UNITED STATES TRIALS
SUMMARY
REFERENCES
The Impact of Worsening Heart Failure in the United States
Key points
INTRODUCTION AND DEFINITIONS
ESTABLISHING A DEFINITION FOR WORSENING HEART FAILURE AS A CLINICAL TRIAL ENDPOINT
INITIAL DESCRIPTIONS OF THE INCIDENCE OF WORSENING HEART FAILURE AND ASSOCIATED OUTCOMES
WORSENING HEART FAILURE AS A TRIAL ENDPOINT
ASSOCIATION OF WORSENING HEART FAILURE WITH CLINICAL OUTCOMES
TREATMENT OF WORSENING HEART FAILURE
PREDICTION OF WORSENING HEART FAILURE
DEVELOPING THERAPEUTICS AND TREATMENT STRATEGIES THAT DECREASE WORSENING HEART FAILURE
SUMMARY
REFERENCES
End-of-life Heart Failure Care in the United States
Key points
INTRODUCTION
RESOURCE USE
PREDICTING DEATH
Hospitalized Setting
Ambulatory Setting
MANAGEMENT OPTIONS
Prolonging Life
Symptom Management
PALLIATIVE CARE AND HOSPICE
CHALLENGES AND SOLUTIONS
SUMMARY
REFERENCES
Epidemiology of Heart Failure in Europe
Key points
INTRODUCTION
PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE
Italian Network on Heart Failure Outcome Registry Findings
European Society of Cardiology Heart Failure Pilot Survey
European Society of Cardiology Heart Failure Long-Term Registry
AMBULATORY PATIENTS WITH CHRONIC HEART FAILURE
Italian Network on Heart Failure Outcome Registry Findings
European Society of Cardiology Heart Failure Pilot and Long-Term registries
SUMMARY
REFERENCES
Acute Heart Failure Syndromes in the Elderly
Key points
INTRODUCTION
CLINICAL PRESENTATION OF ELDERLY PATIENTS WITH ACUTE HEART FAILURE
COMORBIDITIES
MANAGEMENT OF ELDERLY PATIENTS WITH ACUTE HEART FAILURE
OUTCOMES OF ELDERLY PATIENTS WITH ACUTE HEART FAILURE
PREDICTORS OF CLINICAL OUTCOMES OF ELDERLY PATIENTS WITH ACUTE HEART FAILURE
COMPARISON OF THE EUROPEAN AND NORTH AMERICAN EXPERIENCE IN ELDERLY WITH ACUTE HEART FAILURE
SUMMARY AND FUTURE DIRECTIONS
REFERENCES
Characteristics of Intensive Care in Patients Hospitalized for Heart Failure in Europe
Key points
INTRODUCTION
DATA SOURCE INFORMATION
INTENSIVE CARE UNIT ADMISSION RATES
BASELINE CHARACTERISTICS OF PATIENTS ADMITTED TO INTENSIVE CARE UNITS
IN-HOSPITAL THERAPIES AND INVASIVE PROCEDURES
INTENSIVE CARE UNIT OUTCOMES
INTENSIVE CARE UNIT TRIAGE
CLINICAL RESEARCH IN THE INTENSIVE CARE UNIT SETTING
EUROPEAN PERSPECTIVES ON TRAINING AND EDUCATION IN CRITICAL CARE
SUMMARY
REFERENCES

Systemvoraussetzungen

Dateiformat: ePUB
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).
Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions oder die App PocketBook (siehe E-Book Hilfe).
E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an.
Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.

Dateiformat: PDF
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).
Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions oder die App PocketBook (siehe E-Book Hilfe).
E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist.
Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.

Als PDF speichern Als Link merken